PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsHemostasis
MeSH D006487 - hemostasis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D006487: 
Hemostasis
$
Success rate
D001777:Blood coagulation
0 Companies
0 Drugs
Success rate
D015539:Platelet activation
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Omrix BiopharmaceuticalsHuman fibrinogen, Human thrombin Evarrest  2013-09-25   
Clinical Trials
Historical Success Rate
Phase 1
40%
2/5
Phase 2
25%
2/8
Phase 3
100%
3/3
Approved: 2Overall Success rate: 10%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Omrix Biopharmaceuticals
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use